![]() |
인쇄하기
취소
|
As the season of human affairs came back again this year, movements of chief executives in pharmaceutical companies has already been made while the industry also paid attention on future plans of those who will be expired with their contracts in the next year.
On the 9th, according to the DailyPharm’s analysis result of major pharmaceutical companies’chief executive officers (CEO) who will be ...